galactosamine has been researched along with silybin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, R; Kiemer, AK; Prockl, J; Schümann, J; Tiegs, G; Vollmar, AM | 1 |
| Chamulitrat, W; Erben, G; Huber, A; Lehmann, WD; Stremmel, W; Thongphasuk, P; Tuma, S | 1 |
| Hashem, RM; Hassan, MG; Hassanin, KM; Mahmoud, MO; Rashed, LA | 1 |
| Ding, Y; Ge, Y; Sun, Z; Tong, Z; Wang, W; Xu, Q; Zhang, S; Zhou, H; Zhou, L | 1 |
4 other study(ies) available for galactosamine and silybin
| Article | Year |
|---|---|
Silibinin protects mice from T cell-dependent liver injury.
Topics: Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Cytoprotection; Enzyme Induction; Galactosamine; Leukocytes; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Recombinant Proteins; RNA, Messenger; Silybin; Silymarin; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2003 |
Significantly greater antioxidant anticancer activities of 2,3-dehydrosilybin than silybin.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; Humans; Hydrogen Peroxide; Keratinocytes; Liver Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Molecular Structure; Reactive Oxygen Species; Silybin; Silymarin | 2008 |
Effect of silibinin and vitamin E on the ASK1-p38 MAPK pathway in D-galactosamine/lipopolysaccharide induced hepatotoxicity.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Galactosamine; Histocytochemistry; Lipopolysaccharides; Liver; Liver Function Tests; MAP Kinase Kinase Kinase 5; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Silybin; Silymarin; Treatment Outcome; Vitamin E | 2016 |
Preclinical validation of silibinin/albumin nanoparticles as an applicable system against acute liver injury.
Topics: Acetaminophen; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Galactosamine; Lipopolysaccharides; Liver; Mice; Nanoparticles; Serum Albumin, Bovine; Silybin | 2022 |